Author

M. Tang-Fichaux

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:E. coli· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2

Frequent Co-Authors

E. Oswald· 2 shared A. J. Roe· 1 shared C. Chagneau· 1 shared C. Guyonnet· 1 shared D. Loubet· 1 shared J. C. Hallam· 1 shared J.-P. Nougayrede· 1 shared M. Penary· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

E. Oswald

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivJun 20, 2022

Oxygen concentration modulates colibactin production

N. Bossuet, C. Guyonnet, C. Chagneau…·J.-P. Nougayrede

This study shows that colibactin production in E. coli is maximal under anoxic conditions and decreases with oxygen concentration, suggesting adaptation to the intestinal environment.

DOI 10.1080/19490976.2023.2222437

E. coliexperimental assay

𝕏 PostBluesky

MicrobiologybioRxivPreprintMar 8, 2022

The therapeutic potential of D-Serine in reducing expression of the cytopathic genotoxin colibactin

J. C. Hallam, N. O'Boyle, N. C. A. Turner…·A. J. Roe

This study shows D-Serine reduces colibactin expression and cytopathic effects in E. coli strains, suggesting its therapeutic potential for preventing colibactin-related diseases.

DOI 10.1101/2022.03.08.483572

E. coliexperimental assay

𝕏 PostBluesky